Humacyte (HUMA) Enterprise Value (2020 - 2026)
Humacyte (HUMA) reported Enterprise Value of -$48.5 million for Q1 2026, up 22.71% year-over-year from -$39.6 million in Q1 2025, and up 3.88% quarter-over-quarter from -$50.5 million in Q4 2025.
Humacyte (HUMA) Enterprise Value (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has 7 years of Enterprise Value data on file, last reported at -$48.5 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$48.5 million, up 22.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$48.5 million (up 22.71% YoY), and the FY2025 annual result was -$50.5 million, down 12.37% from the prior year.
- Enterprise Value climbed to -$48.5 million in Q1 2026 per HUMA's latest filing, from -$50.5 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$19.5 million in Q3 2025 and troughed at -$206.2 million in Q1 2022.
- A 5-year average of -$96.4 million and a median of -$93.6 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value tumbled 40094.6% in 2022, then surged 79.4% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$151.9 million in 2022, then jumped by 47.03% to -$80.4 million in 2023, then soared by 44.14% to -$44.9 million in 2024, then decreased by 12.37% to -$50.5 million in 2025, then grew by 3.88% to -$48.5 million in 2026.
- Business Quant data shows HUMA's Enterprise Value at -$48.5 million in Q1 2026, -$50.5 million in Q4 2025, and -$19.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -584.73 Mn |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn | -48.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.54 Mn |
| Dec 31, 2025 | -50.50 Mn |
| Sep 30, 2025 | -19.50 Mn |
| Jun 30, 2025 | -38.03 Mn |
| Mar 31, 2025 | -62.80 Mn |
| Dec 31, 2024 | -44.94 Mn |
| Sep 30, 2024 | -20.60 Mn |
| Jun 30, 2024 | -93.56 Mn |
| Mar 31, 2024 | -115.50 Mn |
| Dec 31, 2023 | -80.45 Mn |
| Sep 30, 2023 | -100.00 Mn |
| Jun 30, 2023 | -114.60 Mn |
| Mar 31, 2023 | -131.68 Mn |
| Dec 31, 2022 | -151.88 Mn |
| Sep 30, 2022 | -171.73 Mn |
| Jun 30, 2022 | -189.04 Mn |
| Mar 31, 2022 | -206.22 Mn |
| Dec 31, 2021 | -225.50 Mn |
| Sep 30, 2021 | -240.40 Mn |
| Jun 30, 2021 | -100.41 Mn |